Recombinant human endostatin improves tumor vasculature and alleviates hypoxia in Lewis lung carcinoma
10.3760/cma.j.issn.1004-4221.2011.01.022
- VernacularTitle:重组内皮抑素对肿瘤血管结构和乏氧改善作用的实验观察
- Author:
Fang PENG
;
Jin WANG
;
Yi ZOU
;
Yong BAO
;
Wenlin HUANG
;
Guangming CHEN
;
Xianrong LUO
;
Ming CHEN
- Publication Type:Journal Article
- Keywords:
Endostatin;
Hypoxia;
Tumor vascular normalization;
Lewis lung carcinomas transplantation,nude mice
- From:
Chinese Journal of Radiation Oncology
2011;20(1):69-72
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate whether recombinant human endostatin can create a time window of vascular normalization prior to vascular pruning to alleviate hypoxia in Lewis lung carcinoma in mice. Methods Kinetic changes in morphology of tumor vasculature in response to recombinant human endostatin were detected under a confocal microscope with immunofluorescent staining in Lewis lung carcinomas in mice. The hypoxic cell fraction of different time was assessed with immunohistochemical staining . Effects on tumor growth were monitored as indicated in the growth curve of tumors . Results Compared with the control group vascularity of the tumors was reduced over time by recombinant human endostatin treatment and significantly regressed for 9 days. During the treatment, pericyte coverage increased at day 3, increased markedly at day 5, and fell again at day 7. The vascular basement membrane was thin and closely associated with endothelial cells after recombinant human endostatin treatment, but appeared thickened, loosely associated with endothelial cells in control tumors. The decrease in hypoxic cell fraction at day 5 after treatment was also found. Tumor growth was not accelerated 5 days after recombinant human endostatin treatment. Conclusions Recombinant human endostatin can normalize tumor vasculature within day 3 to 7, leading to improved tumor oxygenation. The results provide important experimental basis for combining recombinant human endostatin with radiation therapy in human tumors.
